| P50 | author | Frédérique Schortgen | Q56807885 |
| P2093 | author name string | Pierre Asfar | |
| P2860 | cites work | Association between source of infection and hospital mortality in patients who have septic shock | Q39229829 |
| | The relationship between hospital volume and mortality in severe sepsis | Q40214469 |
| | Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial | Q41711197 |
| | Association of postdischarge rehabilitation with mortality in intensive care unit survivors of sepsis. | Q41743549 |
| | Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit | Q44620888 |
| | Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication | Q48347646 |
| | Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock | Q49092664 |
| | Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. | Q51241980 |
| | Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. | Q54221826 |
| | Albumin replacement in patients with severe sepsis or septic shock | Q56974736 |
| | High versus Low Blood-Pressure Target in Patients with Septic Shock | Q57016679 |
| | Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change? | Q22306306 |
| | Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 |
| | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Q29615429 |
| | A randomized trial of protocol-based care for early septic shock | Q29617931 |
| | A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group | Q29620037 |
| | Derivation of urine output thresholds that identify a very high risk of AKI in patients with septic shock. | Q33835712 |
| | Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock | Q33901670 |
| | Risk of cardiovascular events in survivors of severe sepsis | Q33901685 |
| | Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality | Q33930693 |
| | Randomized controlled trial of calcitriol in severe sepsis | Q34425809 |
| | A functional synonymous coding variant in the IL1RN gene is associated with survival in septic shock. | Q34425911 |
| | The growth of acute kidney injury: a rising tide or just closer attention to detail? | Q34439098 |
| | Lower versus higher hemoglobin threshold for transfusion in septic shock | Q34441107 |
| | Goal-directed resuscitation for patients with early septic shock | Q34441276 |
| | Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis | Q34480188 |
| | Increased 1-year healthcare use in survivors of severe sepsis | Q34480307 |
| | Rosuvastatin for sepsis-associated acute respiratory distress syndrome | Q34559446 |
| | Chronic dialysis and death among survivors of acute kidney injury requiring dialysis | Q34659135 |
| | The new normal: immunomodulatory agents against sepsis immune suppression | Q37686624 |
| | Hospital case volume and outcomes among patients hospitalized with severe sepsis | Q37688496 |
| | Acute kidney injury and chronic kidney disease as interconnected syndromes | Q38225657 |
| | Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. | Q38244204 |
| | Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial | Q38423032 |
| | Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial. | Q38443294 |
| | Electronic implementation of a novel surveillance paradigm for ventilator-associated events. Feasibility and validation. | Q38450738 |
| | Exploring the scope of post-intensive care syndrome therapy and care: engagement of non-critical care providers and survivors in a second stakeholders meeting. | Q39149968 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| | acute kidney injury | Q424337 |
| P304 | page(s) | 1226-1231 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Update in sepsis and acute kidney injury 2014 | |
| P478 | volume | 191 | |